AlphaCrest Capital Management LLC raised its stake in shares of Xylem Inc. (NYSE:XYL – Get Rating) by 73.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 7,292 shares of the industrial products company’s stock after purchasing an additional 3,098 shares during the period. AlphaCrest Capital Management LLC’s holdings in Xylem were worth $637,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of XYL. First Trust Advisors LP grew its holdings in Xylem by 399.3% during the first quarter. First Trust Advisors LP now owns 2,951,349 shares of the industrial products company’s stock valued at $251,632,000 after purchasing an additional 2,360,214 shares during the period. Vanguard Group Inc. boosted its stake in shares of Xylem by 7.6% in the first quarter. Vanguard Group Inc. now owns 20,390,911 shares of the industrial products company’s stock worth $1,738,529,000 after acquiring an additional 1,435,798 shares during the period. Invesco Ltd. boosted its stake in shares of Xylem by 53.6% in the first quarter. Invesco Ltd. now owns 3,828,177 shares of the industrial products company’s stock worth $326,390,000 after acquiring an additional 1,335,241 shares during the period. Renaissance Technologies LLC boosted its stake in shares of Xylem by 613.3% in the first quarter. Renaissance Technologies LLC now owns 1,183,400 shares of the industrial products company’s stock worth $100,897,000 after acquiring an additional 1,017,500 shares during the period. Finally, Robeco Schweiz AG boosted its stake in shares of Xylem by 159.6% in the first quarter. Robeco Schweiz AG now owns 648,700 shares of the industrial products company’s stock worth $55,308,000 after acquiring an additional 398,855 shares during the period. Institutional investors own 83.57% of the company’s stock.
Xylem Trading Down 0.4 %
Shares of XYL stock opened at $101.77 on Thursday. Xylem Inc. has a 1 year low of $72.08 and a 1 year high of $118.58. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.89 and a quick ratio of 1.39. The stock’s 50 day simple moving average is $106.98 and its two-hundred day simple moving average is $103.11. The company has a market cap of $18.35 billion, a PE ratio of 51.92, a price-to-earnings-growth ratio of 2.66 and a beta of 1.07.
Xylem Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 22nd. Stockholders of record on Wednesday, February 22nd will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 1.30%. This is an increase from Xylem’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend is Tuesday, February 21st. Xylem’s dividend payout ratio is presently 67.35%.
Insider Transactions at Xylem
In other news, SVP Hayati Yarkadas sold 15,942 shares of the stock in a transaction that occurred on Thursday, March 2nd. The stock was sold at an average price of $100.43, for a total value of $1,601,055.06. Following the sale, the senior vice president now directly owns 12,146 shares in the company, valued at $1,219,822.78. The sale was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 0.89% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities analysts have recently weighed in on XYL shares. Cowen upped their price objective on Xylem from $115.00 to $120.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 14th. StockNews.com lowered Xylem from a “buy” rating to a “hold” rating in a research note on Friday, February 17th. Raymond James lowered Xylem from a “market perform” rating to an “underperform” rating in a research note on Wednesday, January 4th. Morgan Stanley boosted their target price on Xylem from $105.00 to $115.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 18th. Finally, Citigroup decreased their target price on Xylem from $123.00 to $121.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 8th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $114.80.
Xylem Profile
Xylem, Inc engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through the following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water.
Read More
- Get a free copy of the StockNews.com research report on Xylem (XYL)
- META Platforms May See its Biggest Opening Yet for New Highs
- Penny Stock Vinco Ventures Could Be Big Winner
- Is Chip Design Specialist Synopsys A Gem Hiding In Plain Sight?
- Should You Park Some Capital with Casey’s General Stores?
- Crowdstrike Stock: While The Iron Is Hot!
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Get Rating).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
